This list is an analysis based on recent market events. It's not an investment recommendation.
About
Shanghai Hile Bio-Technology Co., Ltd. develops, manufactures, and sells in vitro diagnostic reagents and oral tissue repair and regeneration materials in China. It operates through two segments: In Vitro Diagnostic Reagents and Oral Tissue Repair and Regeneration Materials. The In Vitro Diagnostic Reagents segment offers biochemical diagnostic reagents, immuno-latex reagents, immune turbidimetry reagents, latex enhanced immune turbidimetry reagents, enzyme-linked immunosorbent products, and related diagnostic kits, including matrix metalloproteinase 3, IV collagen, adiponectin, creatine kinase isoenzyme, hepatic bile acid, cardiac troponin I, heparin binding protein, hemoglobin A1C, lipoprotein phospholipase A2, heart fatty acid binding protein, ferritin, sialoglycoside antigen, and procalcitonin kits. The Oral Tissue Repair and Regeneration Materials segment provides oral bone repair materials, implant systems, natural bone repair materials, oral restorative films, collagen-based bone repair matrices, and soft tissue repair matrices, primarily for dental implantation and maxillofacial bone defect repair. The company was founded in 1981 and is headquartered in Shanghai, China.
What is Shanghai Hile Bio-Technology stock price today?▼
The current price of 603718.SHG is ¥3.87 CNY — it has decreased by -2.76% in the past 24 hours. Watch Shanghai Hile Bio-Technology stock price performance more closely on the chart.
What is Shanghai Hile Bio-Technology stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Shanghai Hile Bio-Technology stocks are traded under the ticker 603718.SHG.
Is Shanghai Hile Bio-Technology stock price growing?▼
603718.SHG stock has fallen by -14.76% compared to the previous week, the month change is a -8.94% fall, over the last year Shanghai Hile Bio-Technology has showed a -44.48% decrease.
What is Shanghai Hile Bio-Technology market cap?▼
Today Shanghai Hile Bio-Technology has the market capitalization of 2.54B
What were Shanghai Hile Bio-Technology earnings last quarter?▼
603718.SHG earnings for the last quarter are 0.02 CNY per share, whereas the estimation was N/A CNY resulting in a N/A surprise. The estimated earnings for the next quarter are N/A CNY per share.
What is Shanghai Hile Bio-Technology revenue for the last year?▼
Shanghai Hile Bio-Technology revenue for the last year amounts to 534.2M CNY.
What is Shanghai Hile Bio-Technology net income for the last year?▼
603718.SHG net income for the last year is 342.36M CNY.
Does Shanghai Hile Bio-Technology pay dividends?▼
Yes, 603718.SHG dividends are paid annual. The last dividend per share was 0.08 CNY. As of today, Dividend Yield (FWD)% is 1.97%.
How many employees does Shanghai Hile Bio-Technology have?▼
As of April 23, 2026, the company has 366 employees.
In which sector is Shanghai Hile Bio-Technology located?▼
Shanghai Hile Bio-Technology operates in the Health & Wellness sector.
When did Shanghai Hile Bio-Technology complete a stock split?▼
The last stock split for Shanghai Hile Bio-Technology was on May 05, 2016 with a ratio of 1.1:1.
Where is Shanghai Hile Bio-Technology headquartered?▼
Shanghai Hile Bio-Technology is headquartered in Shanghai, China.